Retour aux appels d'offres

Achat de médicaments J01XA01 vancomycine, H01BA01 argipressine, N05AH04 quétiapine, N06BA04 méthylphénidate, N02AA05 oxycodone

Ouvert
Date limite
6 jours restants
Mars 09, 2026
Détails du contrat
Catégorie
Fournitures
Référence
306340
Valeur
€47,300
Lieu
Estonia, Estonie
Publié
Février 16, 2026
Code CPV
Critères d'évaluation
Cost from price quotation form 4100%
Calendrier du projet

Publication de l'appel d'offres

Février 16, 2026

Date limite pour les questions

Mars 02, 2026

Date limite de soumission

Mars 09, 2026

Ouverture de l'appel d'offres

Mars 09, 2026

Probabilité de gainPRO
🔒
Passer au Professionnel
Consultez votre probabilité de gain estimée basée sur les données historiques.
Passer au Professionnel →
Intelligence acheteurPRO
🔒
Débloquer l'intelligence acheteur
Consultez les modèles de dépenses, les procédures préférées et plus encore.
Passer au Professionnel →
Aperçu du secteurPRO
🔒
Débloquer les aperçus du secteur
Consultez les prix gagnants moyens, les niveaux de concurrence et les tendances du marché.
Passer au Professionnel →
Budget
€47,300
Durée
Non spécifié
Lieu
Estonia
Type
Fournitures
75
Score de qualité/100
Bon
Référentiel de marché
Prix moyen gagnant
€92,792
Offres moyennes
2.2
Concurrence
Faible
PME gagnantes
86%
3,220 appels d'offres analysés

Description originale de l'appel d'offres

L'objectif du marché public est de conclure un ou plusieurs contrats d'achat pour la fourniture de médicaments répondant aux exigences énoncées dans l'annexe 1 du HAD.
Soumission électronique

Analyse des risques

Veuillez vous connecter pour utiliser l'analyse des risques.

Se connecter

Stratégie gagnante

Connectez-vous pour accéder aux recommandations de stratégie gagnante.

Se connecter

Concurrents

Passez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.

Se connecter

Exigences et qualifications

14 exigences dans 5 catégories

Soumission (6)
Obligatoire (1)
Conformité (3)
Technique (1)
Financier (3)
SUBMISSION REQUIREMENTS6
--Submit an electronic European Single Procurement Document (ESPD) according to the contracting authority's requirements.
--Complete and submit the participation application form (Vorm 1) as part of the bid.
--If submitting a joint bid, provide a power of attorney (Vorm 3) authorizing one partner to represent all members in the procurement procedure.
MANDATORY EXCLUSION GROUNDS1
--Meet the mandatory exclusion grounds as specified in the European Single Procurement Document (ESPD).
ELIGIBILITY REQUIREMENTS3
--Comply with the general terms and conditions for participation in the procurement of the specified medicines.
--Accept the terms and legal framework of the draft procurement contract.
--Comply with the submission compliance conditions, including declaring business secrets and accepting the terms and conditions.
TECHNICAL CAPABILITY REQUIREMENTS1
--Offer medicines (vancomycin, argipressin, quetiapine, methylphenidate, oxycodone) that meet the specified technical specifications, including ATC codes, forms, and quantities for a two-year period.
FINANCIAL REQUIREMENTS3
--Submit unit prices and total bid value using the provided price quotation form (Vorm 4).
--Offer the lowest possible price, as cost is the sole evaluation criterion (100%).
--Structure the bid cost as specified in the compliance conditions.

Aperçu des exigences

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Documents

10 documents disponibles avec des résumés IA

VastavustingimusedPDF
306340_vastavustingimused.pdf -- 33.4 KB

This document details the compliance conditions for tender submission, including requirements for joint bidders' power of attorney, declaration of business secrets, acceptance of terms, and bid cost structure.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
306340_hindamiskriteeriumid.pdf -- 7.5 KB

This document outlines the tender evaluation criteria, stating that the sole criterion is cost (100%), with the lowest price receiving the maximum points.

Hankepass täiendatavate selgitustegaPDF
306340_hankepass_taiendavate_selgitustega.pdf -- 63.8 KB

This document is an explanatory guide to the conditions and completion of the European Single Procurement Document (ESPD), outlining the contracting authority's requirements and the company information to be submitted electronically.

Lisa 2 Hankelepingu vormDOC
HAD_Lisa_2_Hankelepingu vorm.doc -- 50.5 KB

This document is a draft contract outlining the terms and legal framework of the future agreement that the successful bidder will be required to accept.

HAD üldosaDOC
HAD_uldosa.doc -- 57.0 KB

This document outlines the general terms and requirements for participating in the procurement of pharmaceuticals J01XA01 vancomycin, H01BA01 argipressin, N05AH04 quetiapine, N06BA04 methylphenidate, N02AA05 oxycodone.

Lisa 1 Tehniline kirjeldusDOC
Lisa_1_Tehniline_kirjeldus_Ravimite_J01XA01_v... -- 32.0 KB

This document outlines the technical specifications for the medicines to be procured (vancomycin, argipressin, quetiapine, methylphenidate, oxycodone), including ATC codes, forms, quantities, and estimated costs for a two-year period.

Vorm 1 Osalemise avaldusDOC
Vorm_1_Hankemenetluses_osalemise avaldus_.doc -- 38.0 KB

This document is a participation application form that must be completed and submitted as part of the tender.

Vorm 2 VolikiriDOC
Vorm_2_Volikiri.doc -- 25.0 KB

This document is a power of attorney, granting authorization to represent the tenderer in the procurement procedure for the purchase of medicines.

Vorm 3 Ühispakkumuse volikiriDOC
Vorm_3_Volitus_ühispakkujad.doc -- 26.5 KB

This document is a power of attorney for submitting a joint bid, authorizing one partner to represent all members of the joint tender in the procurement procedure.

Vorm 4 Hinnapakkumuse vormXLS
Vorm_4_ Hinnapakkumuse vorm.xlsx -- 13.0 KB

This is a price quotation form where the bidder must provide the names, manufacturers, and unit prices for specific medicines (vancomycin, argipressin, quetiapine, methylphenidate, oxycodone) to calculate the total offer cost.

Aperçu des documents

Inscrivez-vous pour consulter les résumés et l'analyse des documents

75
Bon

Score de qualité de l'appel d'offres

This tender is well-structured and clear, providing comprehensive requirements and transparent evaluation criteria. While strong in fairness and clarity, minor gaps exist in the completeness of basic information and the absence of sustainability considerations.

Répartition du score

Conformité légale75/100

The tender generally adheres to legal requirements, utilizing ESPD and electronic submission. Deadlines are reasonable, and there are no reported disputes. However, the procedure type is generically defined as "A", which could be more specific.

Generic procedure type "A"
Clarté85/100

The tender documentation, including AI-extracted requirements and specific annexes, is highly clear and unambiguous. Evaluation criteria (100% cost) are explicitly stated, ensuring transparency for bidders.

Exhaustivité70/100

Most essential information, such as title, organization, value, and deadlines, is present. However, the NUTS code is missing, and the explicit contract duration is not stated in the main summary, though implied in technical specifications.

Missing NUTS code
Explicit contract duration not in main summary
Équité90/100

The tender demonstrates high fairness with full document access, disclosed value, reasonable submission period, and objective, transparent evaluation criteria (lowest price). E-procurement ensures equal access, and requirements appear generic.

Aspect pratique70/100

Electronic submission is supported, enhancing practicality. However, the contract start date is not explicitly provided, and a direct URL to all tender documents is not in the basic information.

Missing explicit contract start date
No direct document URL in basic info
Cohérence des données85/100

Data is largely consistent across the provided information. Key fields are populated, and there are no disputes. Dates are logical. The automated check's flag regarding evaluation criteria is contradicted by the document content.

Minor gaps in populated fields (e.g., NUTS code)
Durabilité20/100

The tender does not incorporate any specific green procurement, social aspects, or innovation focus. This is common for standard pharmaceutical procurements but limits its sustainability score.

Absence of green, social, or innovation criteria

Points forts

Clear and comprehensive requirements
Transparent evaluation criteria (100% cost)
Electronic submission enabled
Full document access
Reasonable submission period

Préoccupations

Generic procedure type
Missing NUTS code
No explicit contract duration in main summary
Absence of sustainability considerations

Recommandations

1. Specify the exact procurement procedure type.
2. Include NUTS code and explicit contract duration in the main tender notice.
3. Consider incorporating sustainability criteria where applicable in future tenders.

Aperçu de la notation IA

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Analyse complète du score de qualité
Répartition détaillée des sous-scores
Aperçu des forces et des préoccupations
Recommandations stratégiques

Aucune carte de crédit requise • Configuration en 2 minutes

Ajouter au Pipeline